Covid-19 Treatment Medicine Market Size with Emerging Trends 2023 | Top Key Players Updates, Business Growing Strategies, Competitive Dynamics, Industry Segmentation and Forecast to 2030

Covid-19 Treatment Medicine Market

Due to the COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during the forecast period 2022-2028. Due to the COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Covid-19 Treatment Medicine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Covid-19 Treatment Medicine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.Oral accounting for % of the Covid-19 Treatment Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mild-to-Moderate COVID-19 segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.The global major manufacturers of Covid-19 Treatment Medicine include Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), Regeneron (Ronapreve) and Yiling Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Covid-19 Treatment Medicine in 2021.This report focuses on Covid-19 Treatment Medicine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Covid-19 Treatment Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.Global Covid-19 Treatment Medicine Market: Segment AnalysisThe research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Major players covered in Covid-19 Treatment Medicine Market are:

Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical

Market Segment by Type:

Oral
Injetion

Market Segment by Application:

Mild-to-Moderate COVID-19
Severe Patient

The Covid-19 Treatment Medicine Market Report offers in-depth analysis and key industry insights to help businesses make informed decisions and reach their goals.

News

Covid-19 Treatment Medicine Market Size with Emerging Trends 2023 | Top Key Players Updates, Business Growing Strategies, Competitive Dynamics, Industry Segmentation and Forecast to 2030

Covid-19 Treatment Medicine Market

Download

How Can We Help?

Make A Difference With TIME BUSINESS NEWS